News

Agreement for the future commercialization and marketing in the U.S. of an investigational intravenous therapy for the urgent reversal of an oral anticoagulant.

CLIA-certified laboratory offers diagnostic tests that identify specific cancer biomarkers.

Landmark silver doughnut-shaped building on the Harwell Campus has been granted £15.6 million for a new imaging centre for biology.

Cangene shareholders to receive US$3.24 per share (C$3.44 per share) in cash.

Stroke remains number one cause of disability and fourth leading cause of death in the United States.

The Pirbright Institute in Surrey has been awarded £4.4 million to work with researchers from universities on a long-term study on the transmission of swine influenza.

Collaboration agreement to develop and evaluate methods for the manufacture of OBI-822 active immunotherapy.

Company now has over 1,700 employees spread across seven production facilities.

The series of investments will support the delivery of the company’s pipeline of new medicines and create a centre for pharmaceutical manufacturing innovation in the UK.

Researchers have determined the structure of the rubella virus capsid protein, which is central to the virus's ability to assemble into an infectious particle.